logo-loader
viewVector Therapeutics

Vector Therapeutics using technology to try and prevent acute Leukemia relapse

Vector Therapeutics Corp CEO Daniel Teper  updates Proactive Investor's Christine Corrado at the 11th Annual Biotech Showcase in San Francisco. The New York based pharma company is focused on providing life-changing, precision-immunotherapy treatments for a variety of cancers, mainly leukemia.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Discovery Metals is well financed and drilling impressive numbers at Cordero...

Discovery Metals Corp. (CVE: DSV) (OTCQX: DSVMF) President and CEO Taj Singh joined Proactive's Steve Darling at the Vancouver Resource Investment Conference 2020. The Toronto-based exploration and development are focused on historic mining districts in Mexico, including its 100%-owned flagship...

2 hours, 27 minutes ago

2 min read